Effect of Variation of ABCB1 and ABCC3 Genotypes on the Survival of Bone Tumor Cases after Chemotherapy |
Yang, Jie
(Department of Pediatric Orthopedics, Shanghai Children's Medical Center, Shanghai Jiaotong University)
Wang, Zhi-Gang (Department of Pediatric Orthopedics, Shanghai Children's Medical Center, Shanghai Jiaotong University) Cai, Hai-Qing (Department of Pediatric Orthopedics, Shanghai Children's Medical Center, Shanghai Jiaotong University) Li, Yu-Chan (Department of Pediatric Orthopedics, Shanghai Children's Medical Center, Shanghai Jiaotong University) Xu, Yun-Lan (Department of Pediatric Orthopedics, Shanghai Children's Medical Center, Shanghai Jiaotong University) |
1 | Bacci G, Bertoni F, Longhi A, et al (2003). Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor. Cancer, 97, 3068-75. DOI ScienceOn |
2 | Borst P, Evers R, Kool M, et al (2000). A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst, 92, 1295-302. DOI ScienceOn |
3 | Caronia D, Patino-Garcia A, Perez-Martinez A, et al (2011). Effect of ABCB1 and ABCC3 polymorphisms on osteosarcoma survival after chemotherapy: a pharmacogenetic study. PLoS One, 6, e26091. DOI |
4 | Cheng Y, Xu J, Guo J, et al (2013). Circulating autoantibody to ABCC3 may be a potential biomarker for esophageal squamous cell carcinoma. Clin Transl Oncol, 15, 398-402. DOI ScienceOn |
5 | Clarke R, Leonessa F, Trock B (2005). Multidrug resistance/Pglycoprotein and breast cancer: review and meta-analysis. Semin Oncol, 32, S9-S15. |
6 | Fromm MF (2002). The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans. Adv Drug Deliv Rev, 54, 1295-310. DOI ScienceOn |
7 | Hao T, Feng W, Zhang J, et al (2012). Association of four ERCC1 and ERCC2 SNPs with survival of bone tumour patients. Asian Pac J Cancer Prev, 13, 3821-4. DOI ScienceOn |
8 | Longhi A, Errani C, De Paolis M, et al (2006). Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev, 32, 423-36. DOI ScienceOn |
9 | Ottaviani G, Jaffe N (2009). The epidemiology of osteosarcoma. Cancer Treat Res, 152, 3-13. DOI ScienceOn |
10 | Partanen L, Staaf J, Tanner M, et al (2012). Amplification and overexpression of the ABCC3 (MRP3) gene in primary breast cancer. Genes Chromosomes Cancer, 51, 832-40. DOI ScienceOn |
11 | Redlich G, Zanger UM, Riedmaier S, et al (2008). Distinction between human cytochrome P450 (CYP) isoforms and identification of new phosphorylation sites by mass spectrometry. J Proteome Res, 7, 4678-88. DOI ScienceOn |
12 | Rost D, Konig J, Weiss G, et al (2001). Expression and localization of the multidrug resistance proteins MRP2 and MRP3 in human gallbladder epithelia. Gastroenterology, 121, 1203-8. DOI ScienceOn |
13 | Wei L, Song XR, Wang XW, et al (2006). Expression of MDR1 and GST-pi in osteosarcoma and soft tissue sarcoma and their correlation with chemotherapy resistance. Zhonghua Zhong Liu Za Zhi, 28, 445-8. |
14 | Salama NN, Yang Z, Bui T, et al (2006). MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells. J Pharm Sci, 95, 2293-308. DOI ScienceOn |
15 | Tahara T, Arisawa T, Shibata T, et al (2007). Multidrug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population. J Gastroenterol Hepatol, 22, 1678-82. DOI ScienceOn |
16 | Tran QN (2013). A novel method for finding non-small cell lung cancer diagnosis biomarkers. BMC Med Genomics, 6, S11. |
17 | Windsor RE, Strauss SJ, Kallis C, et al (2012). Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study. Cancer, 118, 1856-67. DOI ScienceOn |
18 | Zeng H, Liu G, Rea PA, et al (2000). Transport of amphipathic anions by human multidrug resistance protein 3. Cancer Res, 60, 4779-84. |
19 | Zelcer N, Saeki T, Reid G, et al (2001). Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3). J Biol Chem, 276, 46400-7. DOI ScienceOn |
20 | Zhou SF, Di YM, Chan E, et al (2008). Clinical pharmacogenetics and potential application in personalized medicine. Curr Drug Metab, 9, 738-84. DOI ScienceOn |